Cord Blood Stem Cells May Help Treat Children with Hearing Loss
New research investigating the use of a child’s own (autologous) umbilical cord blood in the treatment of hearing loss has yielded positive results, as reported in the Journal of Audiology and Otology. Over 2,000 babies are born in Canada every year with hearing loss...
Expanded access to cord blood therapy for cerebral palsy and autism patients
Children with various brain disorders, such as autism and cerebral palsy, who have their own or a sibling’s cord blood stored in a family bank may now be able to receive cord blood therapy. The cord blood therapy is being provided by Duke University Medical Centre...
New Cord Blood Research Shows Improvements in Cerebral Palsy
Results published this week, in Stem Cells Translational Medicine, find the use of umbilical cord blood stem cells increases motor function and brain connectivity in children with cerebral palsy (CP). The phase 2 clinical trial, conducted at the world leading Duke...
Canadian Company Initiates Clinical Trial Using an Expanded Cord Blood for Acute Myeloid Leukemia (AML)
Research Update- AML Trial ExCellThera is a clinical stage biotech company that is focused on developing a robust and cost effective technology to expand blood stem cells from cord blood for therapeutic use. ExCellThera is a spin-off company from the Institute for...
